Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anti-snoring Treatment Market

Anti-snoring Treatment Market Size

  • Report ID: GMI3998
  • Published Date: Dec 2024
  • Report Format: PDF

Anti-snoring Treatment Market Size

The global anti-snoring treatment market size was valued at around USD 1.5 billion in 2024 and is estimated to grow at 8.5% CAGR from 2025 to 2034. Anti-snoring treatments aim to reduce or eliminate snoring. Snoring happens when airflow through the throat and nasal passages is partially blocked during sleep, causing nearby tissues to vibrate. These treatments target the root causes of snoring, which can include nasal congestion, poor sleep posture, obesity, or anatomical issues like a deviated septum or enlarged tonsils.

 

The rising prevalence of sleep disorders is poised to fuel the growth of the global anti-snoring treatment market in the coming years. Sleep disorders can significantly impact both the quality and duration of sleep. Statistics from the Parliament of Australia highlight the issue: one in five Australians grapples with a major sleep disorder. Furthermore, chronic and severe snoring can lead to serious health issues, including sleep apnea, breathing obstructions, and certain cardiovascular conditions. Thus, as sleep disorder cases rise, so too will the demand for anti-snoring treatments.
 

Additionally, aging is a primary factor that exacerbates snoring. For example, the Asia Pacific region, as reported by the Economic and Social Commission for Asia and the Pacific (ESCAP), boasts over 630 million individuals aged 60 and above, accounting for 60% of the global elderly demographic. As individuals age, weight accumulation around the neck narrows the throat, and changes in sleeping habits and relaxed throat muscles during sleep further heighten the risk of snoring. Given the growing elderly population worldwide, the demand for anti-snoring devices is set to surge in the coming years.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global anti-snoring treatment industry was valued at USD 1.5 billion in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2034, driven by the increasing prevalence of sleep disorders.

The CPAP devices segment generated USD 426.3 million in 2024 and is expected to grow significantly during the forecast period as they are the standard treatment for obstructive sleep apnea (OSA) and snoring.

The U.S. anti-snoring treatment industry recorded USD 559 million in 2024 and is anticipated to witness substantial growth, driven by rising awareness about sleep disorders and their health impacts.

Key players in the market include AccuMED, Airing, Airway Management, Apnea Sciences, Fisher & Paykel Healthcare, GlaxoSmithKline, Illusion Aligners, Koninklijke Philips, Meditas, ResMed, Sleeping Well, and SomnoMed.

Anti-snoring Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 15
  • Tables & Figures: 109
  • Countries covered: 27
  • Pages: 135
 Download Free Sample